Literature DB >> 18483244

Myc-mediated transcriptional repression by recruitment of histone deacetylase.

John F Kurland1, William P Tansey.   

Abstract

Myc is a transcription factor that features prominently in cancer. The oncogenicity of Myc stems from its ability to regulate expression of genes required for cell growth and proliferation. Although the mechanisms through which Myc activates transcription have been extensively studied, less is known about how Myc represses transcription. Recently, we reported that a conserved element within Myc-MbIII- is important for transcriptional repression. Here, we investigate the mechanism through which MbIII contributes to repression. We show that Myc represses transcription of target genes Id2 and Gadd153 by a process that involves histone deacetylation. We show that MbIII is important for repression of these genes and present evidence that this element contributes to repression by recruiting the histone deacetylase HDAC3 to the Id2 and Gadd153 promoters. These results describe a mechanistic role for MbIII in transcription, and reveal that recruitment of HDAC3 is a process by which Myc represses gene activity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18483244     DOI: 10.1158/0008-5472.CAN-07-6552

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  57 in total

1.  Epigenetic reprogramming of Myc target genes.

Authors:  Stefano Amente; Luigi Lania; Barbara Majello
Journal:  Am J Cancer Res       Date:  2011-02-06       Impact factor: 6.166

2.  Myc represses miR-15a/miR-16-1 expression through recruitment of HDAC3 in mantle cell and other non-Hodgkin B-cell lymphomas.

Authors:  X Zhang; X Chen; J Lin; T Lwin; G Wright; L C Moscinski; W S Dalton; E Seto; K Wright; E Sotomayor; J Tao
Journal:  Oncogene       Date:  2011-10-17       Impact factor: 9.867

3.  pVHL-mediated transcriptional repression of c-Myc by recruitment of histone deacetylases.

Authors:  In-Young Hwang; Jae-Seok Roe; Ja-Hwan Seol; Hwa-Ryeon Kim; Eun-Jung Cho; Hong-Duk Youn
Journal:  Mol Cells       Date:  2012-02       Impact factor: 5.034

4.  Expression of the class 1 histone deacetylases HDAC8 and 3 are associated with improved survival of patients with metastatic melanoma.

Authors:  James S Wilmott; Andrew J Colebatch; Hojabr Kakavand; Ping Shang; Matteo S Carlino; John F Thompson; Georgina V Long; Richard A Scolyer; Peter Hersey
Journal:  Mod Pathol       Date:  2015-04-03       Impact factor: 7.842

Review 5.  CCAAT/enhancer-binding proteins and the pathogenesis of retrovirus infection.

Authors:  Yujie Liu; Michael R Nonnemacher; Brian Wigdahl
Journal:  Future Microbiol       Date:  2009-04       Impact factor: 3.165

6.  Histone deacetylase inhibition reveals a tumor-suppressive function of MYC-regulated miRNA in breast and lung carcinoma.

Authors:  C M Adams; C M Eischen
Journal:  Cell Death Differ       Date:  2016-02-26       Impact factor: 15.828

7.  Transcriptional Repression of IFN Regulatory Factor 7 by MYC Is Critical for Type I IFN Production in Human Plasmacytoid Dendritic Cells.

Authors:  Tae Whan Kim; Seunghee Hong; Yin Lin; Elise Murat; HyeMee Joo; Taeil Kim; Virginia Pascual; Yong-Jun Liu
Journal:  J Immunol       Date:  2016-09-14       Impact factor: 5.422

8.  Sin3b interacts with Myc and decreases Myc levels.

Authors:  Pablo Garcia-Sanz; Andrea Quintanilla; M Carmen Lafita; Gema Moreno-Bueno; Lucia García-Gutierrez; Vedrana Tabor; Ignacio Varela; Yuzuru Shiio; Lars-Gunnar Larsson; Francisco Portillo; Javier Leon
Journal:  J Biol Chem       Date:  2014-06-20       Impact factor: 5.157

9.  Mad3 negatively regulates B cell differentiation in the spleen by inducing Id2 expression.

Authors:  Yael Gore; Frida Lantner; Gili Hart; Idit Shachar
Journal:  Mol Biol Cell       Date:  2010-04-07       Impact factor: 4.138

Review 10.  MYC protein interactors in gene transcription and cancer.

Authors:  Diana Resetca; Cornelia Redel; Corey Lourenco; Peter Lin; Alannah S MacDonald; Roberto Ciaccio; Tristan M G Kenney; Yong Wei; David W Andrews; Maria Sunnerhagen; Cheryl H Arrowsmith; Brian Raught; Linda Z Penn
Journal:  Nat Rev Cancer       Date:  2021-06-29       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.